Press Room

There are 1 item(s) tagged with the keyword "Special Diabetes Program".

1. JDRF Applauds FDA''s Approval of Lucentis to Treat Diabetic Macular Edema

JDRF is pleased by the U.S. Food and Drug Administration's (FDA) announcement today that it has approved the drug Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME)-a major complication of diabetes and a leading cause of significant vision loss and blindness in adults...


Lets turn type one into type none